Literature DB >> 18007549

Mechanisms of angiogenesis in chronic inflammatory liver disease.

Maria Chaparro1, Paloma Sanz-Cameno, Maria Trapero-Marugan, Luisa Garcia-Buey, Ricardo Moreno-Otero.   

Abstract

Intrahepatic hypoxia may occur during the inflammatory and fibrotic processes that characterize several chronic liver diseases of viral and autoimmune origin. As a consequence, new vascular structures are formed to provide oxygen and nutrients. Angiogenesis involves a tightly regulated network of cellular and molecular mechanisms that result in the formation of functional vessels. Of particular importance are growth factors and molecules involved in matrix remodeling and cell migration, as weel as vessel maturation-related factors. In recent years a number of studies have investigated the expression and function of many pro- and antiangiogenic molecules in chronic liver diseases and liver regeneration. This review examines the potential pathogenic role of angiogenesis in the context of viral hepatitis, autoinmmune hepatitis, primary biliary cirrhosis and hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007549

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  21 in total

1.  Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Authors:  Nan Wu; Fanyin Meng; Tianhao Zhou; Yuyan Han; Lindsey Kennedy; Julie Venter; Heather Francis; Sharon DeMorrow; Paolo Onori; Pietro Invernizzi; Francesca Bernuzzi; Romina Mancinelli; Eugenio Gaudio; Antonio Franchitto; Shannon Glaser; Gianfranco Alpini
Journal:  FASEB J       Date:  2017-06-20       Impact factor: 5.191

2.  Angiogenesis: a phenomenon which aggravates chronic liver disease progression.

Authors:  Michał Kukla
Journal:  Hepatol Int       Date:  2012-07-26       Impact factor: 6.047

Review 3.  Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis.

Authors:  Dmitry Victorovich Garbuzenko; Nikolay Olegovich Arefyev; Dmitry Vladimirovich Belov
Journal:  World J Hepatol       Date:  2016-06-08

4.  Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration.

Authors:  U Shergill; A Das; D Langer; Rs Adluri; N Maulik; V H Shah
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05       Impact factor: 3.619

5.  Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure.

Authors:  Kazuhiro Kotoh; Masaki Kato; Motoyuki Kohjima; Masatake Tanaka; Masayuki Miyazaki; Kazuhiko Nakamura; Munechika Enjoji; Makoto Nakamuta; Ryoichi Takayanagi
Journal:  Exp Ther Med       Date:  2011-01-19       Impact factor: 2.447

Review 6.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

7.  Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks.

Authors:  Hila Barash; Eitan R Gross; Yifat Edrei; Ezra Ella; Ariel Israel; Irit Cohen; Nathalie Corchia; Tehila Ben-Moshe; Orit Pappo; Eli Pikarsky; Daniel Goldenberg; Yosef Shiloh; Eithan Galun; Rinat Abramovitch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

8.  Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma.

Authors:  Paloma Sanz-Cameno; María Trapero-Marugán; María Chaparro; Evan Anthony Jones; Ricardo Moreno-Otero
Journal:  J Oncol       Date:  2010-05-27       Impact factor: 4.375

Review 9.  Angiogenesis in the kidney: a new therapeutic target?

Authors:  Lilach O Lerman; Alejandro R Chade
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-03       Impact factor: 2.894

Review 10.  New insights on the role of vascular endothelial growth factor in biliary pathophysiology.

Authors:  Valeria Mariotti; Romina Fiorotto; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  JHEP Rep       Date:  2021-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.